HealthCor Management, L.P.
Q4 2022 13F Holdings
- Locationnew york, NY
- Num holdings
22
- Value ($000)
$109,112
- Date Filed 02/15/2023
- Form type13F-HR
- CIK 0001343781
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2022 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
B BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | $38.06M | 35 % | 367,765 | ||
D DEXCOM INC | COM | 252131107 | $36.39M | 33 % | 321,380 | ||
C CYTOKINETICS INC | COM NEW | 23282W605 | $7.53M | 7 % | 164,440 | ||
A ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | $3.27M | 3 % | 284,201 | ||
H HYPERFINE INC | COM CL A | 44916K106 | $3.26M | 3 % | 3,880,900 | ||
ALKERMES PLC | SHS | G01767105 | $2.87M | 3 % | 110,000 | ||
C CONMED CORP | COM | 207410101 | $2.44M | 2 % | 27,500 | ||
N NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | $2.39M | 2 % | 20,000 | ||
S SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | $1.78M | 2 % | 70,000 | ||
K CHINOOK THERAPEUTICS INC | COM | 16961L106 | $1.57M | 1 % | 60,000 |
Rows Per Page
10
- 10
- 50
- 100